United States Mydriatic Eyedrops Market Report 2018

Publisher Name :
Date: 16-May-2018
No. of pages: 109
Inquire Before Buying

In this report, the United States Mydriatic Eyedrops market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Mydriatic Eyedrops in these regions, from 2013 to 2025 (forecast).

United States Mydriatic Eyedrops market competition by top manufacturers/players, with Mydriatic Eyedrops sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Novartis AG

- Allergan, Inc.

- Meda Pharmaceuticals Inc

- Bausch & Lomb Inc

- Cigna

- Similasan Corporation

- Visine

- Alcon

- Viva Opti-Free

- Bausch & Lomb

- Systane

- Rite Aid

- Walgreens

- Staples

- Clear eyes

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Atropine

- Homatropine

- Dolly

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Adult

- Children

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Mydriatic Eyedrops Market Report 2018

Table of Contents
United States Mydriatic Eyedrops Market Report 2018
1 Mydriatic Eyedrops Overview
1.1 Product Overview and Scope of Mydriatic Eyedrops
1.2 Classification of Mydriatic Eyedrops by Product Category
1.2.1 United States Mydriatic Eyedrops Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Mydriatic Eyedrops Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Atropine
1.2.4 Homatropine
1.2.5 Dolly
1.2.6 Others
1.3 United States Mydriatic Eyedrops Market by Application/End Users
1.3.1 United States Mydriatic Eyedrops Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Adult
1.3.3 Children
1.4 United States Mydriatic Eyedrops Market by Region
1.4.1 United States Mydriatic Eyedrops Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Mydriatic Eyedrops Status and Prospect (2013-2025)
1.4.3 Southwest Mydriatic Eyedrops Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Mydriatic Eyedrops Status and Prospect (2013-2025)
1.4.5 New England Mydriatic Eyedrops Status and Prospect (2013-2025)
1.4.6 The South Mydriatic Eyedrops Status and Prospect (2013-2025)
1.4.7 The Midwest Mydriatic Eyedrops Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Mydriatic Eyedrops (2013-2025)
1.5.1 United States Mydriatic Eyedrops Sales and Growth Rate (2013-2025)
1.5.2 United States Mydriatic Eyedrops Revenue and Growth Rate (2013-2025)
2 United States Mydriatic Eyedrops Market Competition by Players/Suppliers
2.1 United States Mydriatic Eyedrops Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Mydriatic Eyedrops Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Mydriatic Eyedrops Average Price by Players/Suppliers (2013-2018)
2.4 United States Mydriatic Eyedrops Market Competitive Situation and Trends
2.4.1 United States Mydriatic Eyedrops Market Concentration Rate
2.4.2 United States Mydriatic Eyedrops Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Mydriatic Eyedrops Manufacturing Base Distribution, Sales Area, Product Type
3 United States Mydriatic Eyedrops Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Mydriatic Eyedrops Sales and Market Share by Region (2013-2018)
3.2 United States Mydriatic Eyedrops Revenue and Market Share by Region (2013-2018)
3.3 United States Mydriatic Eyedrops Price by Region (2013-2018)
4 United States Mydriatic Eyedrops Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Mydriatic Eyedrops Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Mydriatic Eyedrops Revenue and Market Share by Type (2013-2018)
4.3 United States Mydriatic Eyedrops Price by Type (2013-2018)
4.4 United States Mydriatic Eyedrops Sales Growth Rate by Type (2013-2018)
5 United States Mydriatic Eyedrops Sales (Volume) by Application (2013-2018)
5.1 United States Mydriatic Eyedrops Sales and Market Share by Application (2013-2018)
5.2 United States Mydriatic Eyedrops Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Mydriatic Eyedrops Players/Suppliers Profiles and Sales Data
6.1 Novartis AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Mydriatic Eyedrops Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novartis AG Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Allergan, Inc.
6.2.2 Mydriatic Eyedrops Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Allergan, Inc. Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Meda Pharmaceuticals Inc
6.3.2 Mydriatic Eyedrops Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Bausch & Lomb Inc
6.4.2 Mydriatic Eyedrops Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bausch & Lomb Inc Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Cigna
6.5.2 Mydriatic Eyedrops Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Cigna Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Similasan Corporation
6.6.2 Mydriatic Eyedrops Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Similasan Corporation Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Visine
6.7.2 Mydriatic Eyedrops Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Visine Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Alcon
6.8.2 Mydriatic Eyedrops Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Alcon Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Viva Opti-Free
6.9.2 Mydriatic Eyedrops Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Viva Opti-Free Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Bausch & Lomb
6.10.2 Mydriatic Eyedrops Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Bausch & Lomb Mydriatic Eyedrops Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Systane
6.12 Rite Aid
6.13 Walgreens
6.14 Staples
6.15 Clear eyes
7 Mydriatic Eyedrops Manufacturing Cost Analysis
7.1 Mydriatic Eyedrops Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Mydriatic Eyedrops
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Mydriatic Eyedrops Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Mydriatic Eyedrops Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Mydriatic Eyedrops Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Mydriatic Eyedrops Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Mydriatic Eyedrops Sales Volume Forecast by Type (2018-2025)
11.3 United States Mydriatic Eyedrops Sales Volume Forecast by Application (2018-2025)
11.4 United States Mydriatic Eyedrops Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Mydriatic Eyedrops
Figure United States Mydriatic Eyedrops Market Size (K Units) by Type (2013-2025)
Figure United States Mydriatic Eyedrops Sales Volume Market Share by Type (Product Category) in 2017
Figure Atropine Product Picture
Figure Homatropine Product Picture
Figure Dolly Product Picture
Figure Others Product Picture
Figure United States Mydriatic Eyedrops Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Mydriatic Eyedrops by Application in 2017
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure Children Examples
Table Key Downstream Customer in Children
Figure United States Mydriatic Eyedrops Market Size (Million USD) by Region (2013-2025)
Figure The West Mydriatic Eyedrops Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Mydriatic Eyedrops Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Mydriatic Eyedrops Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Mydriatic Eyedrops Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Mydriatic Eyedrops Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Mydriatic Eyedrops Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Mydriatic Eyedrops Sales (K Units) and Growth Rate (2013-2025)
Figure United States Mydriatic Eyedrops Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Mydriatic Eyedrops Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Mydriatic Eyedrops Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Mydriatic Eyedrops Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Mydriatic Eyedrops Sales Share by Players/Suppliers
Figure 2017 United States Mydriatic Eyedrops Sales Share by Players/Suppliers
Figure United States Mydriatic Eyedrops Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Mydriatic Eyedrops Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Mydriatic Eyedrops Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Mydriatic Eyedrops Revenue Share by Players/Suppliers
Figure 2017 United States Mydriatic Eyedrops Revenue Share by Players/Suppliers
Table United States Market Mydriatic Eyedrops Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Mydriatic Eyedrops Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Mydriatic Eyedrops Market Share of Top 3 Players/Suppliers
Figure United States Mydriatic Eyedrops Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Mydriatic Eyedrops Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Mydriatic Eyedrops Product Category
Table United States Mydriatic Eyedrops Sales (K Units) by Region (2013-2018)
Table United States Mydriatic Eyedrops Sales Share by Region (2013-2018)
Figure United States Mydriatic Eyedrops Sales Share by Region (2013-2018)
Figure United States Mydriatic Eyedrops Sales Market Share by Region in 2017
Table United States Mydriatic Eyedrops Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Mydriatic Eyedrops Revenue Share by Region (2013-2018)
Figure United States Mydriatic Eyedrops Revenue Market Share by Region (2013-2018)
Figure United States Mydriatic Eyedrops Revenue Market Share by Region in 2017
Table United States Mydriatic Eyedrops Price (USD/Unit) by Region (2013-2018)
Table United States Mydriatic Eyedrops Sales (K Units) by Type (2013-2018)
Table United States Mydriatic Eyedrops Sales Share by Type (2013-2018)
Figure United States Mydriatic Eyedrops Sales Share by Type (2013-2018)
Figure United States Mydriatic Eyedrops Sales Market Share by Type in 2017
Table United States Mydriatic Eyedrops Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Mydriatic Eyedrops Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Mydriatic Eyedrops by Type (2013-2018)
Figure Revenue Market Share of Mydriatic Eyedrops by Type in 2017
Table United States Mydriatic Eyedrops Price (USD/Unit) by Types (2013-2018)
Figure United States Mydriatic Eyedrops Sales Growth Rate by Type (2013-2018)
Table United States Mydriatic Eyedrops Sales (K Units) by Application (2013-2018)
Table United States Mydriatic Eyedrops Sales Market Share by Application (2013-2018)
Figure United States Mydriatic Eyedrops Sales Market Share by Application (2013-2018)
Figure United States Mydriatic Eyedrops Sales Market Share by Application in 2017
Table United States Mydriatic Eyedrops Sales Growth Rate by Application (2013-2018)
Figure United States Mydriatic Eyedrops Sales Growth Rate by Application (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis AG Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Novartis AG Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Novartis AG Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Allergan, Inc. Basic Information List
Table Allergan, Inc. Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan, Inc. Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Allergan, Inc. Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Allergan, Inc. Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Meda Pharmaceuticals Inc Basic Information List
Table Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Meda Pharmaceuticals Inc Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Bausch & Lomb Inc Basic Information List
Table Bausch & Lomb Inc Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bausch & Lomb Inc Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Bausch & Lomb Inc Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Bausch & Lomb Inc Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Cigna Basic Information List
Table Cigna Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cigna Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Cigna Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Cigna Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Similasan Corporation Basic Information List
Table Similasan Corporation Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Similasan Corporation Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Similasan Corporation Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Similasan Corporation Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Visine Basic Information List
Table Visine Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Visine Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Visine Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Visine Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Alcon Basic Information List
Table Alcon Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Alcon Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Alcon Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Alcon Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Viva Opti-Free Basic Information List
Table Viva Opti-Free Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Viva Opti-Free Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Viva Opti-Free Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Viva Opti-Free Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Bausch & Lomb Basic Information List
Table Bausch & Lomb Mydriatic Eyedrops Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bausch & Lomb Mydriatic Eyedrops Sales Growth Rate (2013-2018)
Figure Bausch & Lomb Mydriatic Eyedrops Sales Market Share in United States (2013-2018)
Figure Bausch & Lomb Mydriatic Eyedrops Revenue Market Share in United States (2013-2018)
Table Systane Basic Information List
Table Rite Aid Basic Information List
Table Walgreens Basic Information List
Table Staples Basic Information List
Table Clear eyes Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Mydriatic Eyedrops
Figure Manufacturing Process Analysis of Mydriatic Eyedrops
Figure Mydriatic Eyedrops Industrial Chain Analysis
Table Raw Materials Sources of Mydriatic Eyedrops Major Players/Suppliers in 2017
Table Major Buyers of Mydriatic Eyedrops
Table Distributors/Traders List
Figure United States Mydriatic Eyedrops Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Mydriatic Eyedrops Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Mydriatic Eyedrops Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Mydriatic Eyedrops Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Mydriatic Eyedrops Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Mydriatic Eyedrops Sales Volume (K Units) Forecast by Type in 2025
Table United States Mydriatic Eyedrops Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Mydriatic Eyedrops Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Mydriatic Eyedrops Sales Volume (K Units) Forecast by Application in 2025
Table United States Mydriatic Eyedrops Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Mydriatic Eyedrops Sales Volume Share Forecast by Region (2018-2025)
Figure United States Mydriatic Eyedrops Sales Volume Share Forecast by Region (2018-2025)
Figure United States Mydriatic Eyedrops Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Glycinates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 137
    Glycine is an amino acid of endogenous antioxidant reductive glutathione. It is often added exogenously in severe stress, sometimes called semi-essential amino acid. Scope of the Report: This report focuses on the Glycinates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The feed additive segment is ......
  • Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 35
    Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Aurora Kinase C is a member of the Aurora sub......
  • Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 74
    Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018 Summary Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) pipeline Target constitutes close to 15 molecules. Out of which app......
  • Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 50
    Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Transforming growth factor beta 2 (TGF-ß2) is a polypeptide member of the transforming growth factor beta superfamily of cytokines encoded by......
  • Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 1 (TGFB1) pipeline Target constitutes close to 22 molecules. Out of which approximately 15 molecules are developed by companies and remaining by the universities/institutes. The latest report Transforming Growth Factor Beta 1- Pipeline Review, H2 2018, outlays comprehensive information on the Transforming Growth Factor Beta 1 (TGFB1) targeted therapeutics, co......
  • Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 69
    Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018 Summary Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Beta-secretase 1 (BACE1) is an enzyme that in humans is encoded by the BACE1 ......
  • Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018 Summary According to the recently published report 'Lysosomal Alpha Glucosidase - Pipeline Review, H2 2018'; Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) pipeline Target constitutes close to 16 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes......
  • Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 56
    Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Glycogen Synthase Kinase 3 Be......
  • Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 80
    Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2018 Summary According to the recently published report 'Caspase 3 - Pipeline Review, H2 2018'; Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) pipeline Target constitutes close to 13 molecules. Out of which approximately 9 molecules are developed by companies a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs